3D Ex Vivo Human Ovary Fibroma Model Introduction

To meet the needs of scientific research and drug development in the field, Creative Biolabs offers 3D ex vivo human ovary fibroma model for global researchers. This model provides researchers with a more realistic and reliable experimental platform to study and evaluate the biological characteristics, and disease mechanisms, and develop new treatment approaches for ovarian fibromas.

Ovarian Fibroma Profile

Fig 1. Ultrasound and pathological features of an ovarian cellular fibroma. Fig 1. Ultrasound examination and pathological findings
proved to be cellular fibroma.¹

Characteristics: Ovarian fibroma is a benign sex cord-stromal tumor that occurs in the ovarian tissue of females.

Pathological Features: Ovarian fibromas typically have a round, oval, kidney-shaped, or lobulated appearance, with a smooth surface and firm, hard texture. They are encapsulated tumors composed mainly of fibroblasts arranged in bundles or interlacing patterns, with these cells being spindle-shaped or oval in morphology.

Clinical Presentation:

1. Ovarian fibromas are usually unilateral, occurring in only one ovary, but in rare cases, they may affect both ovaries simultaneously.

2. Ovarian fibromas are commonly found in young to middle-aged women, but they can also occur at other ages.

3. Small fibromas may be asymptomatic, while larger ones can cause symptoms such as lower abdominal pain, abdominal enlargement, and urinary abnormalities.

4. Ovarian fibromas are easy to be torqued, leading to acute abdominal symptoms.

5. In a minority of patients, the formation of pleural or abdominal effusions can occur, known as Meigs syndrome. This syndrome is characterized by the resolution of ascites and pleural effusion upon tumor removal, with no recurrence thereafter.

Treatment methods: The treatment of ovarian fibromas in humans depends on the patient's symptoms, tumor size, and location, as well as their age and fertility plans. Common treatment options include observation, medication therapy, surgical removal, radiation therapy, and targeted therapy.

Why Choose the 3D Ex Vivo Human Ovarian Fibroma Model?

Reflecting real physiological environment

3D ex vivo models can better simulate the microenvironment of ovarian fibromas in the human body, including cell-cell interactions, cell-matrix interactions, and tissue structure. Compared to traditional 2D cell cultures and animal models, 3D models closely resemble the growth and development process of fibromas in the human body, providing more reliable research results.

Evaluating drug efficacy

By using 3D ex vivo models, researchers can more accurately assess the therapeutic efficacy of candidate drugs for ovarian fibromas. These models can be used to test drug inhibitory effects, cell proliferation, apoptosis, and the sensitivity of tumor cells to drugs, helping to screen and optimize potential therapeutic agents.

In-depth study of disease mechanisms

By establishing 3D ex vivo models, researchers can delve deeper into the disease mechanisms of ovarian fibromas. This model can help uncover key factors such as the mechanisms of tumor occurrence, growth regulation, and cell signaling pathways, aiding in understanding the disease's development process and potential therapeutic targets.

Advantages of 3D Ex Vivo Human Ovarian Fibroma Model Construction at Creative Biolabs

Source Advantage
Surgical samples obtained from ovarian fibroma patients.
Culturing Advantage
Professional division and digestion processes; appropriate culturing conditions.
Identification Advantage
Detection of ovarian fibroma biomarkers, such as Vimentin and Inhibin-α, using cell phenotyping analysis techniques.
Evaluation Advantage
Provision of comprehensive functional evaluation experiments and reliable experimental data.

In addition to the 3D ex vivo human ovarian fibroma model, Creative Biolabs also offers various other 3D ex vivo human ovarian tissue models, including:

If you have been searching for a preclinical efficacy assessment model of human ovarian tissue that can truly aid in the evaluation of candidate drugs, please contact us.

Reference

Chen, H.; et al. Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison. J Ovarian Res. 2016, 9(1): 81. Distributed under Open Access License CC BY 4.0. The original image was modified by keeping part (a) & (c).

Research Model

3D Biology Based Biomarker Discovery

3D Biology Based Drug Discovery and Development

3D Biology Based Toxicity Evaluation

Supporting Assays

Related Sections:

Research Models

Services

Online Inquiry